parecoxib has been researched along with Hepatopulmonary Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belguise, K; Chen, B; Chen, L; Gao, J; Liu, C; Lu, K; Wang, X; Yi, B; Yu, W | 1 |
1 other study(ies) available for parecoxib and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
Topics: Animals; Bone Morphogenetic Protein 2; Carrier Proteins; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endothelium, Vascular; Hepatopulmonary Syndrome; Injections, Intraperitoneal; Injections, Intravenous; Isoxazoles; Lung; Macrophage Activation; Macrophages, Alveolar; Microvessels; Neovascularization, Pathologic; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction | 2017 |